Although some genetic alterations such as BRAF, RAS, CTNNB1, TP53, and EGFR mutations have been associated with thyroid cancer, additional molecular mechanisms are thought to be involved in the formation and progression of TC [28–32]. This evidence concerns the gene CTNNB1 and thyroid gland carcinoma.